Upcoming Therapeutic Targets in Cutaneous Lupus Erythematous.
about
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.The Increased Expression of Toll-Like Receptor 4 in Renal and Skin Lesions in Lupus Erythematosus.Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature.JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus.
P2860
Upcoming Therapeutic Targets in Cutaneous Lupus Erythematous.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Upcoming Therapeutic Targets in Cutaneous Lupus Erythematous.
@en
type
label
Upcoming Therapeutic Targets in Cutaneous Lupus Erythematous.
@en
prefLabel
Upcoming Therapeutic Targets in Cutaneous Lupus Erythematous.
@en
P2860
P1476
Upcoming Therapeutic Targets in Cutaneous Lupus Erythematous.
@en
P2093
Anna Sophie Klaeschen
Joerg Wenzel
P2860
P356
10.1586/17512433.2016.1145543
P407
P577
2016-01-22T00:00:00Z